| Timothy John Ciolkosz, DC | |
|
3105 Limestone Rd, Suite303, Wilmington, DE 19808-2147 | |
| (302) 993-9113 | |
| (302) 993-0313 |
| Full Name | Timothy John Ciolkosz |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 29 Years |
| Location | 3105 Limestone Rd, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013987221 | NPI | - | NPPES |
| 522088872 | Other | DE | BCBS |
| 1040507 | Other | DE | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | F1 0000424 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrative Physical Health Llc | 4981017282 | 2 |
News Archive
Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its innovative cardiovascular product portfolio, technology pipeline and clinical research at the world's premier annual meeting for interventional cardiologists.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
President Obama on Friday named New York City Health Commissioner Thomas Frieden as the next CDC director, the New York Times reports. It has long been expected that Obama would select Frieden, an infectious disease specialist, according to the Times.
Despite a decade of initiatives to remedy health disparities in cardiovascular medicine, at least some aspects of the treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race, according to a study by researchers at Emory University in collaboration with Yale University and other centers.
Researchers in the United States have demonstrated the effectiveness of early treatment with REGEN-COV™ at preventing symptomatic disease among people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 1 days ago
| Provider Name | Family Chiropractic Office, P.a. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851591143 PECOS PAC ID: 7719992494 Enrollment ID: O20060216000377 |
News Archive
Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its innovative cardiovascular product portfolio, technology pipeline and clinical research at the world's premier annual meeting for interventional cardiologists.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
President Obama on Friday named New York City Health Commissioner Thomas Frieden as the next CDC director, the New York Times reports. It has long been expected that Obama would select Frieden, an infectious disease specialist, according to the Times.
Despite a decade of initiatives to remedy health disparities in cardiovascular medicine, at least some aspects of the treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race, according to a study by researchers at Emory University in collaboration with Yale University and other centers.
Researchers in the United States have demonstrated the effectiveness of early treatment with REGEN-COV™ at preventing symptomatic disease among people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 1 days ago
| Provider Name | Integrative Physical Health Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477166270 PECOS PAC ID: 4981017282 Enrollment ID: O20210105003040 |
News Archive
Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its innovative cardiovascular product portfolio, technology pipeline and clinical research at the world's premier annual meeting for interventional cardiologists.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
President Obama on Friday named New York City Health Commissioner Thomas Frieden as the next CDC director, the New York Times reports. It has long been expected that Obama would select Frieden, an infectious disease specialist, according to the Times.
Despite a decade of initiatives to remedy health disparities in cardiovascular medicine, at least some aspects of the treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race, according to a study by researchers at Emory University in collaboration with Yale University and other centers.
Researchers in the United States have demonstrated the effectiveness of early treatment with REGEN-COV™ at preventing symptomatic disease among people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy John Ciolkosz, DC 3105 Limestone Rd, Suite 303, Wilmington, DE 19808-2147 Ph: (302) 993-9113 | Timothy John Ciolkosz, DC 3105 Limestone Rd, Suite303, Wilmington, DE 19808-2147 Ph: (302) 993-9113 |
News Archive
Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its innovative cardiovascular product portfolio, technology pipeline and clinical research at the world's premier annual meeting for interventional cardiologists.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
President Obama on Friday named New York City Health Commissioner Thomas Frieden as the next CDC director, the New York Times reports. It has long been expected that Obama would select Frieden, an infectious disease specialist, according to the Times.
Despite a decade of initiatives to remedy health disparities in cardiovascular medicine, at least some aspects of the treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race, according to a study by researchers at Emory University in collaboration with Yale University and other centers.
Researchers in the United States have demonstrated the effectiveness of early treatment with REGEN-COV™ at preventing symptomatic disease among people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 1 days ago
Shavneet Kler, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3411 Silverside Road., 106 Weldin Building, Wilmington, DE 19810 Phone: 302-650-4542 Fax: 302-371-9800 | |
Matthew Paul Weik, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1426 N Clayton St, Wilmington, DE 19806 Phone: 302-300-4242 Fax: 302-300-4241 | |
Joseph George Gaglioti, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1400 Philadelphia Pike, Suite A4, Wilmington, DE 19809 Phone: 302-778-9996 Fax: 302-296-0996 | |
Dr. Desiree Paramore, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 6 Sharpley Rd, Wilmington, DE 19803 Phone: 850-980-2206 | |
Dr. Nicole Jean Stoessel, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2207 Concord Pike # 207, Wilmington, DE 19803 Phone: 302-256-8622 Fax: 302-340-7444 | |
Newlife Spinal Care Centers Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1305 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-994-6575 Fax: 302-994-2374 |